US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

2.28

-0.0900-3.80%

Post-market: 2.280.00000.00%16:04 EST

Volume:20.44K

Turnover:48.00K

Market Cap:93.67M

PE:-9.09

High:2.39

Open:2.33

Low:2.28

Close:2.37

52wk High:3.42

52wk Low:0.8001

Shares:41.08M

Float Shares:3.40M

Volume Ratio:1.09

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2509

EPS(LYR):-0.2509

ROE:-109.69%

ROA:-71.09%

PB:8.04

PE(LYR):-9.09

Loading ...

Overview Company News Filings

Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate

Anebulo Pharmaceuticals posts Q1 net loss

Anebulo Pharmaceuticals Board Approves Reverse Stock Split

Anebulo Pharmaceuticals reports first quarter net loss of $0.05 per share

Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)

Anebulo Pharmaceuticals, Inc. Q1 EPS USD -0.05

THOMSON REUTERS

Press Release: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Anebulo Pharmaceuticals Inc expected to post a loss of 12 cents a share - Earnings Preview

Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split

Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment

BRIEF-Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results

Anebulo Pharmaceuticals Fiscal Q4 Loss Unchanged

MT Newswires Live

Anebulo Pharmaceuticals Q4 EPS $(0.05) Beats $(0.08) Estimate

Anebulo Pharmaceuticals, Inc. Q4 EPS USD -0.05

THOMSON REUTERS

Press Release: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals Initiates Phase 1 Clinical Trial of IV Selonabant for Acute Cannabis-Induced Toxicity in Children

Anebulo Pharmaceuticals doses first subjects in selonabant study

Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, Under Development for Acute Cannabis-Induced Toxicity

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global

BUZZ-Anebulo rises as it weighs going-private deal after getting fresh options

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANEB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANEB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANEB\",,,,,undefined,":{"symbol":"ANEB","market":"US","secType":"STK","nameCN":"Anebulo Pharmaceuticals, Inc.","latestPrice":2.28,"timestamp":1763154000000,"preClose":2.37,"halted":0,"volume":20435,"hourTrading":{"tag":"盘后","latestPrice":2.28,"preClose":2.28,"latestTime":"16:04 EST","volume":1,"amount":2.28,"timestamp":1763154247848},"delay":0,"floatShares":3401326,"shares":41084731,"eps":-0.250877,"marketStatus":"Market Closed","change":-0.09,"latestTime":"11-14 16:00:00 EST","open":2.33,"high":2.39,"low":2.28,"amount":47998.5606,"amplitude":0.046414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.250877,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1763370000000},"marketStatusCode":7,"adr":0,"listingDate":1620360000000,"exchange":"NASDAQ","adjPreClose":2.37,"postHourTrading":{"tag":"盘后","latestPrice":2.28,"preClose":2.28,"latestTime":"16:04 EST","volume":1,"amount":2.28,"timestamp":1763154247848},"volumeRatio":1.0912401801266671},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANEB\",,,,,undefined,":{"symbol":"ANEB","floatShares":3401326,"roa":"-71.09%","roe":"-109.69%","lyrEps":-0.250877,"volumeRatio":1.0912401801266671,"shares":41084731,"dividePrice":0,"high":2.39,"amplitude":0.046414,"preClose":2.37,"low":2.28,"week52Low":0.8001,"pbRate":"8.04","week52High":3.42,"institutionHeld":0,"latestPrice":2.28,"eps":-0.250877,"divideRate":0,"volume":20435,"delay":0,"ttmEps":-0.250877,"open":2.33,"prevYearClose":1.68,"prevWeekClose":2.42,"prevMonthClose":2.64,"prevQuarterClose":2.5,"fiveDayClose":2.42,"twentyDayClose":2.66,"sixtyDayClose":2.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANEB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"ANEB","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2025-09-29","symbol":"ANEB","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2025-05-13","symbol":"ANEB","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2025-02-14","symbol":"ANEB","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2024-11-13","symbol":"ANEB","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANEB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANEB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1753419600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANEB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANEB","date":"2025-11-14","current":-9.088119,"percent":0.153777,"low":-198.730098,"twenty":-9.753815,"median":-5.943128,"eighty":-4.926454,"high":-1.875087,"avg":-19.595238,"sd":43.114415,"marketCap":97370812},"quantilePoints":[{"date":"2021-05-07","current":-157.65181,"twenty":-100.37308,"median":-14.454984,"eighty":-14.454984,"marketCap":165191035},{"date":"2021-05-14","current":-156.097497,"twenty":-156.941266,"median":-155.76443,"eighty":-70.845535,"marketCap":163562391},{"date":"2021-05-21","current":-198.730098,"twenty":-157.65181,"median":-156.097497,"eighty":-155.431362,"marketCap":208233769},{"date":"2021-05-28","current":-182.076738,"twenty":-177.635843,"median":-157.429765,"eighty":-155.431362,"marketCap":190784012},{"date":"2021-06-04","current":-163.20293,"twenty":-177.635843,"median":-160.42737,"eighty":-155.52018,"marketCap":171007621},{"date":"2021-06-11","current":-183.186962,"twenty":-177.635843,"median":-163.20293,"eighty":-155.91986,"marketCap":191947329},{"date":"2021-06-18","current":-162.092706,"twenty":-177.635843,"median":-166.350415,"eighty":-156.186315,"marketCap":169844303},{"date":"2021-06-25","current":-160.186975,"twenty":-177.635843,"median":-162.63768,"eighty":-155.91986,"marketCap":167847436},{"date":"2021-07-02","current":-146.373912,"twenty":-176.570028,"median":-160.371859,"eighty":-154.958258,"marketCap":153373805},{"date":"2021-07-09","current":-164.827719,"twenty":-172.306767,"median":-160.251662,"eighty":-154.839982,"marketCap":172710110},{"date":"2021-07-16","current":-152.612069,"twenty":-172.306767,"median":-160.186975,"eighty":-154.839982,"marketCap":159910283},{"date":"2021-07-23","current":-156.17673,"twenty":-170.880959,"median":-160.07558,"eighty":-154.839982,"marketCap":163645414},{"date":"2021-07-30","current":-161.710868,"twenty":-169.420185,"median":-158.734375,"eighty":-155.431362,"marketCap":169444205},{"date":"2021-08-06","current":-165.756758,"twenty":-169.420185,"median":-159.349279,"eighty":-155.431362,"marketCap":173683578},{"date":"2021-08-13","current":-155.468254,"twenty":-169.19814,"median":-160.186975,"eighty":-155.431362,"marketCap":162903057},{"date":"2021-08-20","current":-157.46892,"twenty":-168.30996,"median":-158.680905,"eighty":-155.431362,"marketCap":164999399},{"date":"2021-08-27","current":-153.726026,"twenty":-168.30996,"median":-157.65181,"eighty":-154.3944,"marketCap":161077512},{"date":"2021-09-03","current":-150.384156,"twenty":-166.533602,"median":-157.33832,"eighty":-153.726026,"marketCap":157575827},{"date":"2021-09-10","current":-153.665872,"twenty":-166.268593,"median":-157.137808,"eighty":-153.726026,"marketCap":161014481},{"date":"2021-09-17","current":-158.181852,"twenty":-166.174251,"median":-157.067896,"eighty":-153.726026,"marketCap":165746425},{"date":"2021-09-24","current":-5.285844,"twenty":-165.838852,"median":-156.637648,"eighty":-153.23232,"marketCap":159910283},{"date":"2021-10-01","current":-5.185529,"twenty":-165.756758,"median":-156.399522,"eighty":-151.81002,"marketCap":156875490},{"date":"2021-10-08","current":-5.077497,"twenty":-165.756758,"median":-156.17673,"eighty":-150.161365,"marketCap":153607250},{"date":"2021-10-15","current":-5.540491,"twenty":-165.756758,"median":-155.95394,"eighty":-147.042286,"marketCap":167613991},{"date":"2021-10-22","current":-5.285844,"twenty":-165.013527,"median":-155.95394,"eighty":-14.454984,"marketCap":159910283},{"date":"2021-10-29","current":-5.131513,"twenty":-163.527888,"median":-155.95394,"eighty":-5.523314,"marketCap":155241370},{"date":"2021-11-05","current":-5.386159,"twenty":-163.107196,"median":-155.599701,"eighty":-5.417026,"marketCap":162945077},{"date":"2021-11-12","current":-4.624581,"twenty":-162.726796,"median":-155.431362,"eighty":-5.401593,"marketCap":145903543},{"date":"2021-11-19","current":-4.757769,"twenty":-162.63768,"median":-154.839982,"eighty":-5.325353,"marketCap":150105565},{"date":"2021-11-26","current":-4.639454,"twenty":-162.310696,"median":-154.505795,"eighty":-5.284208,"marketCap":146372769},{"date":"2021-12-03","current":-5.046343,"twenty":-161.863603,"median":-153.848561,"eighty":-5.21797,"marketCap":159209946},{"date":"2021-12-10","current":-4.703236,"twenty":-161.598581,"median":-153.726026,"eighty":-5.177812,"marketCap":148385071},{"date":"2021-12-17","current":-4.883558,"twenty":-161.523723,"median":-153.331685,"eighty":-5.140773,"marketCap":154074142},{"date":"2021-12-23","current":-4.705974,"twenty":-161.085182,"median":-152.612069,"eighty":-5.068237,"marketCap":148471446},{"date":"2021-12-31","current":-4.550588,"twenty":-160.420328,"median":-151.609508,"eighty":-5.046343,"marketCap":143569087},{"date":"2022-01-07","current":-4.994548,"twenty":-160.372399,"median":-150.384156,"eighty":-4.95544,"marketCap":157575827},{"date":"2022-01-14","current":-5.102726,"twenty":-160.264599,"median":-148.768918,"eighty":-4.967703,"marketCap":160988802},{"date":"2022-01-21","current":-5.179531,"twenty":-160.142417,"median":-147.153682,"eighty":-4.985254,"marketCap":163411969},{"date":"2022-01-28","current":-5.105537,"twenty":-159.718222,"median":-146.596702,"eighty":-4.985254,"marketCap":161077512},{"date":"2022-02-04","current":-5.305319,"twenty":-158.712987,"median":-14.454984,"eighty":-4.985254,"marketCap":167380545},{"date":"2022-02-11","current":-4.836049,"twenty":-158.538319,"median":-5.601293,"eighty":-4.962627,"marketCap":156175153},{"date":"2022-02-18","current":-4.959444,"twenty":-158.181852,"median":-5.571209,"eighty":-4.93317,"marketCap":160160070},{"date":"2022-02-25","current":-5.060141,"twenty":-158.181852,"median":-5.507696,"eighty":-4.927954,"marketCap":163411969},{"date":"2022-03-04","current":-4.857735,"twenty":-157.73627,"median":-5.417026,"eighty":-4.927954,"marketCap":156875490},{"date":"2022-03-11","current":-4.940649,"twenty":-157.65181,"median":-5.409309,"eighty":-4.927954,"marketCap":159553112},{"date":"2022-03-18","current":-4.337264,"twenty":-157.65181,"median":-5.401593,"eighty":-4.923166,"marketCap":140067402},{"date":"2022-03-25","current":-4.893879,"twenty":-157.46892,"median":-5.396963,"eighty":-4.900016,"marketCap":158042718},{"date":"2022-04-01","current":-5.161344,"twenty":-157.20772,"median":-5.325584,"eighty":-4.898356,"marketCap":166680208},{"date":"2022-04-08","current":-4.966167,"twenty":-157.067896,"median":-5.295581,"eighty":-4.898356,"marketCap":160377175},{"date":"2022-04-14","current":-3.94691,"twenty":-157.067896,"median":-5.283799,"eighty":-4.890957,"marketCap":127461335},{"date":"2022-04-22","current":-3.108372,"twenty":-156.800546,"median":-5.257061,"eighty":-4.883558,"marketCap":100381638},{"date":"2022-04-29","current":-2.681875,"twenty":-156.580011,"median":-5.231547,"eighty":-4.877975,"marketCap":86608343},{"date":"2022-05-06","current":-2.877051,"twenty":-156.517052,"median":-5.201729,"eighty":-4.832232,"marketCap":92911376},{"date":"2022-05-13","current":-2.166767,"twenty":-156.421801,"median":-5.189929,"eighty":-4.809564,"marketCap":72835049},{"date":"2022-05-20","current":-2.208436,"twenty":-156.399522,"median":-5.179531,"eighty":-4.791457,"marketCap":74235723},{"date":"2022-05-27","current":-2.041761,"twenty":-156.221288,"median":-5.178635,"eighty":-4.754809,"marketCap":68633026},{"date":"2022-06-03","current":-2.076485,"twenty":-156.17673,"median":-5.177812,"eighty":-4.704879,"marketCap":69800255},{"date":"2022-06-10","current":-2.201491,"twenty":-156.12919,"median":-5.176719,"eighty":-4.675178,"marketCap":74002277},{"date":"2022-06-17","current":-1.882032,"twenty":-156.011363,"median":-5.164958,"eighty":-4.550588,"marketCap":63263776},{"date":"2022-06-24","current":-3.465439,"twenty":-155.95394,"median":-5.150531,"eighty":-4.5122,"marketCap":116489389},{"date":"2022-07-01","current":-3.812608,"twenty":-155.95394,"median":-5.117971,"eighty":-4.337264,"marketCap":128159338},{"date":"2022-07-08","current":-3.194593,"twenty":-155.95394,"median":-5.105537,"eighty":-4.098714,"marketCap":107385008},{"date":"2022-07-15","current":-2.152878,"twenty":-155.95394,"median":-5.100432,"eighty":-3.912212,"marketCap":72368157},{"date":"2022-07-22","current":-2.215381,"twenty":-155.95394,"median":-5.09293,"eighty":-3.62378,"marketCap":74469168},{"date":"2022-07-29","current":-2.073013,"twenty":-155.938242,"median":-5.061603,"eighty":-3.307177,"marketCap":69683532},{"date":"2022-08-05","current":-2.715404,"twenty":-155.84659,"median":-5.060141,"eighty":-3.096864,"marketCap":91277256},{"date":"2022-08-12","current":-2.673735,"twenty":-155.678569,"median":-5.046343,"eighty":-2.998137,"marketCap":89876582},{"date":"2022-08-19","current":-2.430668,"twenty":-155.460876,"median":-5.038454,"eighty":-2.930692,"marketCap":81705984},{"date":"2022-08-26","current":-2.326497,"twenty":-155.431362,"median":-5.020371,"eighty":-2.887172,"marketCap":78204299},{"date":"2022-09-02","current":-2.208436,"twenty":-155.431362,"median":-4.994548,"eighty":-2.808847,"marketCap":74235723},{"date":"2022-09-09","current":-13.181073,"twenty":-155.431362,"median":-4.982931,"eighty":-2.770962,"marketCap":89968982},{"date":"2022-09-16","current":-11.845847,"twenty":-154.839982,"median":-5.005647,"eighty":-2.784851,"marketCap":80855241},{"date":"2022-09-23","current":-9.620471,"twenty":-154.839982,"median":-5.038454,"eighty":-2.791796,"marketCap":65665673},{"date":"2022-09-30","current":-9.586235,"twenty":-154.617191,"median":-5.042399,"eighty":-2.877051,"marketCap":65431987},{"date":"2022-10-07","current":-10.339439,"twenty":-154.3944,"median":-5.054347,"eighty":-2.882078,"marketCap":70573072},{"date":"2022-10-14","current":-9.243869,"twenty":-154.283004,"median":-5.060641,"eighty":-2.88428,"marketCap":63095130},{"date":"2022-10-21","current":-6.722241,"twenty":-153.848561,"median":-5.077497,"eighty":-2.88428,"marketCap":45883458},{"date":"2022-10-28","current":-9.388605,"twenty":-153.726026,"median":-5.098138,"eighty":-2.898738,"marketCap":64083042},{"date":"2022-11-04","current":-10.327466,"twenty":-153.726026,"median":-5.105537,"eighty":-2.905967,"marketCap":70491346},{"date":"2022-11-11","current":-8.908484,"twenty":-153.726026,"median":-5.111754,"eighty":-2.909857,"marketCap":70235014},{"date":"2022-11-18","current":-7.803052,"twenty":-153.665872,"median":-5.146946,"eighty":-2.930692,"marketCap":61519720},{"date":"2022-11-25","current":-8.030641,"twenty":-153.398522,"median":-5.161344,"eighty":-2.930692,"marketCap":63314045},{"date":"2022-12-02","current":-8.61587,"twenty":-152.934225,"median":-5.174425,"eighty":-2.934044,"marketCap":67928025},{"date":"2022-12-09","current":-10.945406,"twenty":-152.656627,"median":-5.177812,"eighty":-2.937085,"marketCap":86294225},{"date":"2022-12-16","current":-7.673001,"twenty":-152.433836,"median":-5.178635,"eighty":-2.975914,"marketCap":60494392},{"date":"2022-12-23","current":-8.697151,"twenty":-152.032812,"median":-5.179531,"eighty":-3.036099,"marketCap":68568855},{"date":"2022-12-30","current":-7.880107,"twenty":-151.542671,"median":-5.185529,"eighty":-3.056419,"marketCap":62127228},{"date":"2023-01-06","current":-8.160692,"twenty":-151.007971,"median":-5.196409,"eighty":-3.074513,"marketCap":64339374},{"date":"2023-01-13","current":-10.338718,"twenty":-150.517831,"median":-5.216434,"eighty":-3.099741,"marketCap":81511066},{"date":"2023-01-20","current":-9.753815,"twenty":-150.384156,"median":-5.243121,"eighty":-3.115893,"marketCap":76899651},{"date":"2023-01-27","current":-8.648707,"twenty":-150.161365,"median":-5.269775,"eighty":-3.155702,"marketCap":68186920},{"date":"2023-02-03","current":-8.973509,"twenty":-149.069687,"median":-5.285844,"eighty":-3.201538,"marketCap":70747678},{"date":"2023-02-10","current":-7.376464,"twenty":-148.067126,"median":-5.324427,"eighty":-3.241817,"marketCap":78470967},{"date":"2023-02-17","current":-7.023941,"twenty":-147.220519,"median":-5.389246,"eighty":-3.307177,"marketCap":74720827},{"date":"2023-02-24","current":-6.987797,"twenty":-147.042286,"median":-5.401593,"eighty":-3.368608,"marketCap":74336329},{"date":"2023-03-03","current":-6.554072,"twenty":-147.042286,"median":-5.401593,"eighty":-3.430715,"marketCap":69722350},{"date":"2023-03-10","current":-6.746598,"twenty":-146.596702,"median":-5.417026,"eighty":-3.465439,"marketCap":71770444},{"date":"2023-03-17","current":-6.91551,"twenty":-146.373912,"median":-5.4749,"eighty":-3.611279,"marketCap":73567332},{"date":"2023-03-24","current":-6.578168,"twenty":-14.454984,"median":-5.561329,"eighty":-3.673782,"marketCap":69978682},{"date":"2023-03-31","current":-6.987797,"twenty":-14.454984,"median":-5.586494,"eighty":-3.771008,"marketCap":74336329},{"date":"2023-04-06","current":-6.927558,"twenty":-13.709748,"median":-5.633089,"eighty":-3.804288,"marketCap":73695498},{"date":"2023-04-14","current":-6.722984,"twenty":-13.249546,"median":-6.096251,"eighty":-3.885351,"marketCap":71519238},{"date":"2023-04-21","current":-6.746839,"twenty":-13.098905,"median":-6.45793,"eighty":-3.938235,"marketCap":71773007},{"date":"2023-04-28","current":-7.084181,"twenty":-13.050974,"median":-6.602264,"eighty":-3.964259,"marketCap":75361657},{"date":"2023-05-05","current":-5.903484,"twenty":-12.496342,"median":-6.554072,"eighty":-3.968596,"marketCap":62801381},{"date":"2023-05-12","current":-5.602286,"twenty":-11.948557,"median":-6.289018,"eighty":-4.061124,"marketCap":59597229},{"date":"2023-05-19","current":-4.568055,"twenty":-11.186618,"median":-6.023963,"eighty":-4.142086,"marketCap":52804427},{"date":"2023-05-26","current":-5.233305,"twenty":-10.960687,"median":-5.879509,"eighty":-4.288276,"marketCap":60494392},{"date":"2023-06-02","current":-5.543756,"twenty":-10.912632,"median":-5.621685,"eighty":-4.330842,"marketCap":64083042},{"date":"2023-06-09","current":-5.37079,"twenty":-10.846468,"median":-5.60179,"eighty":-4.337264,"marketCap":62083651},{"date":"2023-06-15","current":-5.100255,"twenty":-10.74413,"median":-5.595766,"eighty":-4.357731,"marketCap":58956399},{"date":"2023-06-23","current":-5.011555,"twenty":-10.600664,"median":-5.586494,"eighty":-4.439598,"marketCap":57931070},{"date":"2023-06-30","current":-5.07808,"twenty":-10.599449,"median":-5.566438,"eighty":-4.439598,"marketCap":58700066},{"date":"2023-07-07","current":-5.210908,"twenty":-10.525489,"median":-5.560928,"eighty":-4.46928,"marketCap":60235496},{"date":"2023-07-14","current":-5.277655,"twenty":-10.432995,"median":-5.543756,"eighty":-4.523766,"marketCap":61007056},{"date":"2023-07-21","current":-5.277655,"twenty":-10.384561,"median":-5.542901,"eighty":-4.549112,"marketCap":61007056},{"date":"2023-07-28","current":-4.98938,"twenty":-10.371556,"median":-5.540491,"eighty":-4.550588,"marketCap":57674738},{"date":"2023-08-04","current":-6.319881,"twenty":-10.371556,"median":-5.541269,"eighty":-4.550588,"marketCap":73054668},{"date":"2023-08-11","current":-6.297706,"twenty":-10.352286,"median":-5.543756,"eighty":-4.561068,"marketCap":72798336},{"date":"2023-08-18","current":-6.519456,"twenty":-10.339006,"median":-5.560928,"eighty":-4.568055,"marketCap":75361657},{"date":"2023-08-25","current":-6.297706,"twenty":-10.331967,"median":-5.566142,"eighty":-4.594665,"marketCap":72798336},{"date":"2023-09-01","current":-6.186831,"twenty":-10.327466,"median":-5.586494,"eighty":-4.619711,"marketCap":71516675},{"date":"2023-09-08","current":-6.253356,"twenty":-10.318561,"median":-5.595766,"eighty":-4.63053,"marketCap":72285671},{"date":"2023-09-15","current":-7.11796,"twenty":-10.305203,"median":-5.606283,"eighty":-4.643879,"marketCap":82280063},{"date":"2023-09-22","current":-7.581376,"twenty":-10.302145,"median":-5.654631,"eighty":-4.666111,"marketCap":88947262},{"date":"2023-09-29","current":-6.620049,"twenty":-10.286122,"median":-5.865957,"eighty":-4.687111,"marketCap":77668647},{"date":"2023-10-06","current":-6.93685,"twenty":-10.250424,"median":-5.903484,"eighty":-4.6986,"marketCap":81385463},{"date":"2023-10-13","current":-5.199906,"twenty":-10.161409,"median":-5.983545,"eighty":-4.699609,"marketCap":61007056},{"date":"2023-10-20","current":-6.357868,"twenty":-10.109999,"median":-5.903484,"eighty":-4.699609,"marketCap":74592661},{"date":"2023-10-27","current":-4.915878,"twenty":-10.061958,"median":-5.898556,"eighty":-4.701422,"marketCap":57674738},{"date":"2023-11-03","current":-4.733007,"twenty":-10.003811,"median":-5.855444,"eighty":-4.704879,"marketCap":55529237},{"date":"2023-11-10","current":-4.632068,"twenty":-9.987672,"median":-5.654631,"eighty":-4.692842,"marketCap":54344983},{"date":"2023-11-17","current":-4.662061,"twenty":-9.970264,"median":-5.606283,"eighty":-4.675371,"marketCap":54086087},{"date":"2023-11-24","current":-4.949297,"twenty":-9.944253,"median":-5.597234,"eighty":-4.689505,"marketCap":57418406},{"date":"2023-12-01","current":-5.037677,"twenty":-9.903373,"median":-5.586494,"eighty":-4.697866,"marketCap":58443734},{"date":"2023-12-08","current":-4.750441,"twenty":-9.87437,"median":-5.566438,"eighty":-4.698625,"marketCap":55111416},{"date":"2023-12-15","current":-4.198064,"twenty":-9.851779,"median":-5.565931,"eighty":-4.698625,"marketCap":48703112},{"date":"2023-12-22","current":-5.570168,"twenty":-9.824588,"median":-5.54984,"eighty":-4.670935,"marketCap":64621340},{"date":"2023-12-29","current":-5.612149,"twenty":-9.802584,"median":-5.565931,"eighty":-4.684245,"marketCap":65108371},{"date":"2024-01-05","current":-5.192343,"twenty":-9.796026,"median":-5.54984,"eighty":-4.692134,"marketCap":60238059},{"date":"2024-01-12","current":-5.302818,"twenty":-9.791654,"median":-5.542046,"eighty":-4.698102,"marketCap":61519720},{"date":"2024-01-19","current":-5.302818,"twenty":-9.791654,"median":-5.542046,"eighty":-4.698625,"marketCap":61519720},{"date":"2024-01-26","current":-5.302818,"twenty":-9.780652,"median":-5.50819,"eighty":-4.700516,"marketCap":61519720},{"date":"2024-02-02","current":-5.678434,"twenty":-9.761457,"median":-5.514706,"eighty":-4.704331,"marketCap":65877367},{"date":"2024-02-09","current":-5.534816,"twenty":-9.755977,"median":-5.541269,"eighty":-4.714923,"marketCap":64211208},{"date":"2024-02-16","current":-6.45133,"twenty":-9.753815,"median":-5.542046,"eighty":-4.73021,"marketCap":67685696},{"date":"2024-02-23","current":-7.168144,"twenty":-9.747312,"median":-5.543756,"eighty":-4.73352,"marketCap":75206329},{"date":"2024-03-01","current":-6.723225,"twenty":-9.718831,"median":-5.550894,"eighty":-4.737051,"marketCap":70538350},{"date":"2024-03-08","current":-7.182481,"twenty":-9.691252,"median":-5.565931,"eighty":-4.743846,"marketCap":75356741},{"date":"2024-03-15","current":-5.981693,"twenty":-9.614887,"median":-5.567346,"eighty":-4.747967,"marketCap":62758385},{"date":"2024-03-22","current":-5.932257,"twenty":-9.592292,"median":-5.579006,"eighty":-4.750441,"marketCap":62239720},{"date":"2024-03-28","current":-6.871532,"twenty":-9.591251,"median":-5.586494,"eighty":-4.750441,"marketCap":72094343},{"date":"2024-04-05","current":-7.192862,"twenty":-9.586235,"median":-5.597234,"eighty":-4.750441,"marketCap":75465661},{"date":"2024-04-12","current":-7.143427,"twenty":-9.586049,"median":-5.610281,"eighty":-4.750441,"marketCap":74946997},{"date":"2024-04-19","current":-7.044556,"twenty":-9.576377,"median":-5.622619,"eighty":-4.752015,"marketCap":73909668},{"date":"2024-04-26","current":-6.907125,"twenty":-9.526226,"median":-5.656339,"eighty":-4.757769,"marketCap":72467781},{"date":"2024-05-03","current":-7.711935,"twenty":-9.517762,"median":-5.678434,"eighty":-4.762939,"marketCap":80911637},{"date":"2024-05-10","current":-7.415322,"twenty":-9.428688,"median":-5.74472,"eighty":-4.762939,"marketCap":77799651},{"date":"2024-05-17","current":-6.131431,"twenty":-9.428688,"median":-5.810431,"eighty":-4.766964,"marketCap":57312409},{"date":"2024-05-24","current":-6.159175,"twenty":-9.415052,"median":-5.855356,"eighty":-4.76763,"marketCap":57571741},{"date":"2024-05-31","current":-5.826246,"twenty":-9.393894,"median":-5.85399,"eighty":-4.770318,"marketCap":54459755},{"date":"2024-06-07","current":-6.006583,"twenty":-9.388605,"median":-5.854673,"eighty":-4.772227,"marketCap":56145414},{"date":"2024-06-14","current":-5.826246,"twenty":-9.315116,"median":-5.854673,"eighty":-4.772555,"marketCap":54459755},{"date":"2024-06-21","current":-5.271366,"twenty":-9.257222,"median":-5.826246,"eighty":-4.774828,"marketCap":49273112},{"date":"2024-06-28","current":-7.29668,"twenty":-9.24832,"median":-5.840118,"eighty":-4.777089,"marketCap":68204360},{"date":"2024-07-05","current":-6.658567,"twenty":-9.179191,"median":-5.855444,"eighty":-4.785171,"marketCap":62239720},{"date":"2024-07-12","current":-6.297895,"twenty":-9.084798,"median":-5.876381,"eighty":-4.789805,"marketCap":58868402},{"date":"2024-07-15","current":-6.852776,"twenty":-9.067707,"median":-5.879058,"eighty":-4.789805,"marketCap":64055045},{"date":"2024-08-02","current":-6.333407,"twenty":-9.050615,"median":-5.881735,"eighty":-4.789805,"marketCap":59200347},{"date":"2024-08-09","current":-5.493318,"twenty":-9.038535,"median":-5.861698,"eighty":-4.794631,"marketCap":51347769},{"date":"2024-08-16","current":-5.382342,"twenty":-9.013061,"median":-5.85399,"eighty":-4.794766,"marketCap":50310440},{"date":"2024-08-23","current":-5.33268,"twenty":-8.973509,"median":-5.826246,"eighty":-4.802266,"marketCap":49846236},{"date":"2024-08-30","current":-5.066615,"twenty":-8.973509,"median":-5.798502,"eighty":-4.806636,"marketCap":47359240},{"date":"2024-09-06","current":-4.993926,"twenty":-8.921489,"median":-5.765506,"eighty":-4.80819,"marketCap":46679790},{"date":"2024-09-13","current":-5.798502,"twenty":-8.887936,"median":-5.717101,"eighty":-4.808579,"marketCap":54200423},{"date":"2024-09-20","current":-5.770758,"twenty":-8.799306,"median":-5.765506,"eighty":-4.809367,"marketCap":53941091},{"date":"2024-09-27","current":-6.197384,"twenty":-8.713407,"median":-5.770758,"eighty":-4.809564,"marketCap":50829105},{"date":"2024-10-04","current":-6.039288,"twenty":-8.658396,"median":-5.798502,"eighty":-4.813461,"marketCap":49532444},{"date":"2024-10-11","current":-5.913127,"twenty":-8.622437,"median":-5.812374,"eighty":-4.814435,"marketCap":48497709},{"date":"2024-10-18","current":-5.786333,"twenty":-8.58986,"median":-5.826246,"eighty":-4.816458,"marketCap":47457787},{"date":"2024-10-25","current":-6.007668,"twenty":-8.552801,"median":-5.826246,"eighty":-4.831249,"marketCap":49273112},{"date":"2024-10-31","current":-5.849572,"twenty":-8.490048,"median":-5.826246,"eighty":-4.835557,"marketCap":47976451},{"date":"2024-11-08","current":-4.648354,"twenty":-8.433798,"median":-5.826246,"eighty":-4.835557,"marketCap":38124422},{"date":"2024-11-15","current":-4.976067,"twenty":-8.342762,"median":-5.818743,"eighty":-4.837917,"marketCap":39418489},{"date":"2024-11-22","current":-4.910592,"twenty":-8.290742,"median":-5.798502,"eighty":-4.850306,"marketCap":38899825},{"date":"2024-11-29","current":-4.714168,"twenty":-8.251727,"median":-5.798502,"eighty":-4.824106,"marketCap":37343832},{"date":"2024-12-06","current":-4.648694,"twenty":-8.193204,"median":-5.786333,"eighty":-4.814435,"marketCap":36825168},{"date":"2024-12-13","current":-4.550482,"twenty":-8.180199,"median":-5.786333,"eighty":-4.809564,"marketCap":36047171},{"date":"2024-12-20","current":-3.633838,"twenty":-8.160692,"median":-5.770758,"eighty":-4.804014,"marketCap":28785870},{"date":"2024-12-27","current":-5.303439,"twenty":-8.154189,"median":-5.755113,"eighty":-4.80314,"marketCap":42011811},{"date":"2025-01-03","current":-5.17249,"twenty":-8.128179,"median":-5.688504,"eighty":-4.806636,"marketCap":40974482},{"date":"2025-01-10","current":-5.336177,"twenty":-8.076159,"median":-5.686139,"eighty":-4.80819,"marketCap":42271143},{"date":"2025-01-17","current":-5.287071,"twenty":-8.038944,"median":-5.678434,"eighty":-4.80819,"marketCap":41882145},{"date":"2025-01-24","current":-5.17249,"twenty":-8.031541,"median":-5.656339,"eighty":-4.808579,"marketCap":40974482},{"date":"2025-01-31","current":-5.205228,"twenty":-8.024789,"median":-5.645138,"eighty":-4.80917,"marketCap":41233815},{"date":"2025-02-07","current":-5.041541,"twenty":-7.993966,"median":-5.632038,"eighty":-4.809564,"marketCap":39937154},{"date":"2025-02-14","current":-4.354058,"twenty":-7.969777,"median":-5.612149,"eighty":-4.80917,"marketCap":34491178},{"date":"2025-02-21","current":-7.582209,"twenty":-7.971857,"median":-5.632038,"eighty":-4.809564,"marketCap":58134894},{"date":"2025-02-28","current":-6.430142,"twenty":-7.959113,"median":-5.635645,"eighty":-4.81069,"marketCap":49301677},{"date":"2025-03-07","current":-5.46562,"twenty":-7.921658,"median":-5.634367,"eighty":-4.81238,"marketCap":41906425},{"date":"2025-03-14","current":-7.662585,"twenty":-7.875295,"median":-5.656339,"eighty":-4.813202,"marketCap":58751165},{"date":"2025-03-21","current":-10.609734,"twenty":-8.00294,"median":-5.669108,"eighty":-4.814435,"marketCap":81347767},{"date":"2025-03-28","current":-7.501832,"twenty":-8.051049,"median":-5.684752,"eighty":-4.815447,"marketCap":57518623},{"date":"2025-04-04","current":-5.787127,"twenty":-8.031991,"median":-5.688504,"eighty":-4.824106,"marketCap":44371509},{"date":"2025-04-11","current":-5.144113,"twenty":-8.026739,"median":-5.684752,"eighty":-4.835312,"marketCap":39441341},{"date":"2025-04-17","current":-5.572789,"twenty":-8.011913,"median":-5.678434,"eighty":-4.836672,"marketCap":42728120},{"date":"2025-04-25","current":-5.787127,"twenty":-7.973938,"median":-5.65806,"eighty":-4.842877,"marketCap":44371509},{"date":"2025-05-02","current":-6.322973,"twenty":-7.962364,"median":-5.678434,"eighty":-4.858371,"marketCap":48479982},{"date":"2025-05-09","current":-5.733543,"twenty":-7.935509,"median":-5.687526,"eighty":-4.861951,"marketCap":43960662},{"date":"2025-05-16","current":-5.396111,"twenty":-7.877701,"median":-5.678434,"eighty":-4.867308,"marketCap":41495578},{"date":"2025-05-23","current":-5.93038,"twenty":-7.868077,"median":-5.678434,"eighty":-4.873639,"marketCap":45604051},{"date":"2025-05-30","current":-5.609819,"twenty":-7.868077,"median":-5.681593,"eighty":-4.879421,"marketCap":43138967},{"date":"2025-06-06","current":-6.021205,"twenty":-7.831152,"median":-5.678434,"eighty":-4.879421,"marketCap":46302491},{"date":"2025-06-13","current":-6.785209,"twenty":-7.823339,"median":-5.687526,"eighty":-4.880598,"marketCap":52177608},{"date":"2025-06-20","current":-8.281161,"twenty":-7.856612,"median":-5.711512,"eighty":-4.882966,"marketCap":63681333},{"date":"2025-06-27","current":-7.586612,"twenty":-7.870483,"median":-5.733543,"eighty":-4.883558,"marketCap":58340318},{"date":"2025-07-03","current":-8.97571,"twenty":-7.907808,"median":-5.765506,"eighty":-4.883558,"marketCap":69022348},{"date":"2025-07-11","current":-9.456551,"twenty":-8.016771,"median":-5.770099,"eighty":-4.883558,"marketCap":72719973},{"date":"2025-07-18","current":-8.762002,"twenty":-8.086244,"median":-5.770758,"eighty":-4.887997,"marketCap":67378958},{"date":"2025-07-25","current":-17.310298,"twenty":-8.173697,"median":-5.786333,"eighty":-4.890957,"marketCap":133114528},{"date":"2025-08-01","current":-14.264968,"twenty":-8.210152,"median":-5.786333,"eighty":-4.89271,"marketCap":109696231},{"date":"2025-08-08","current":-12.822443,"twenty":-8.296685,"median":-5.792815,"eighty":-4.893879,"marketCap":98603354},{"date":"2025-08-15","current":-13.03615,"twenty":-8.429052,"median":-5.798502,"eighty":-4.896565,"marketCap":100246743},{"date":"2025-08-22","current":-13.143004,"twenty":-8.546415,"median":-5.817953,"eighty":-4.899352,"marketCap":101068438},{"date":"2025-08-29","current":-13.463565,"twenty":-8.620365,"median":-5.823526,"eighty":-4.900602,"marketCap":103533522},{"date":"2025-09-05","current":-12.769016,"twenty":-8.736062,"median":-5.826246,"eighty":-4.904833,"marketCap":98192507},{"date":"2025-09-12","current":-10.738796,"twenty":-8.804744,"median":-5.837909,"eighty":-4.910632,"marketCap":82580309},{"date":"2025-09-19","current":-13.196431,"twenty":-8.947499,"median":-5.85399,"eighty":-4.910783,"marketCap":101479285},{"date":"2025-09-26","current":-13.03615,"twenty":-8.998121,"median":-5.861698,"eighty":-4.912777,"marketCap":100246743},{"date":"2025-10-03","current":-11.621227,"twenty":-9.1522,"median":-5.876953,"eighty":-4.91569,"marketCap":98603354},{"date":"2025-10-10","current":-11.282274,"twenty":-9.328327,"median":-5.885789,"eighty":-4.917748,"marketCap":95727423},{"date":"2025-10-17","current":-12.202288,"twenty":-9.423234,"median":-5.898556,"eighty":-4.920554,"marketCap":103533522},{"date":"2025-10-24","current":-13.170724,"twenty":-9.504441,"median":-5.912968,"eighty":-4.92145,"marketCap":111750468},{"date":"2025-10-31","current":-12.783349,"twenty":-9.586161,"median":-5.932257,"eighty":-4.922943,"marketCap":108463689},{"date":"2025-11-07","current":-12.105444,"twenty":-9.619015,"median":-5.932257,"eighty":-4.924282,"marketCap":102711827},{"date":"2025-11-14","current":-11.475961,"twenty":-9.753815,"median":-5.943128,"eighty":-4.926454,"marketCap":97370812}],"updateTime":1763209409243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANEB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583298512","title":"Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583298512","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583298512?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:33","pubTimestamp":1763069621,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses of $(0.08) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48851451/anebulo-pharmaceuticals-q1-eps-0-05-beats-0-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB"],"gpt_icon":0},{"id":"2583951404","title":"Anebulo Pharmaceuticals posts Q1 net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2583951404","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583951404?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:18","pubTimestamp":1763068697,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals posts Q1 net lossOverviewAnebulo fiscal Q1 net loss remains at $2.2 mln, consistent with last yearOperating expenses for fiscal Q1 decreased slightly to $2.3 mlnCompany advance","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP181:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"2583514067","title":"Anebulo Pharmaceuticals Board Approves Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514067","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514067?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:17","pubTimestamp":1763068655,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Inc. has announced that its Board of Directors has approved a proposed reverse stock split of the company's common stock, pending approval by stockholders at a future special meeting. The date of the meeting has not yet been determined, and the Board is continuing to review all strategic alternatives available to the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anebulo Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL6P2DjQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2583451443","title":"Anebulo Pharmaceuticals reports first quarter net loss of $0.05 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2583451443","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583451443?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:14","pubTimestamp":1763068477,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Inc. reported cash and cash equivalents of $10.4 million as of September 30, 2025, compared to $11.6 million as of June 30, 2025. Total assets stood at $10.7 million, while total liabilities were $1.0 million. Total stockholders' equity was $9.7 million, down from $11.7 million at the previous fiscal year-end. The company reported a net loss per share of $0.05 for the quarter. During the period, Anebulo initiated dosing in a Phase 1 single ascending dose study of its lead drug candidate, selonabant, in an intravenous formulation for the treatment of acute cannabis-induced toxicity in children.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anebulo Pharmaceuticals Inc. published the original content used to gener","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL46d0V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2583151238","title":"Anebulo Pharmaceuticals reports Q1 EPS (5c), one estimate (12c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583151238","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583151238?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:12","pubTimestamp":1763068341,"startTime":"0","endTime":"0","summary":"“We have made significant progress towards our goal of providing the first emergency antidote for acute cannabis-induced toxicity in children,” com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anebulo-pharmaceuticals-reports-q1-eps-5c-one-estimate-12c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anebulo-pharmaceuticals-reports-q1-eps-5c-one-estimate-12c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANEB"],"gpt_icon":0},{"id":"2583112555","title":"Anebulo Pharmaceuticals, Inc. Q1 EPS USD -0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2583112555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583112555?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXCBF380:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2583916514","title":"Press Release: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583916514","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583916514?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects , today announced financial results for the three months ended September 30, 2025, and recent updates.First Quarter Fiscal Year 2026 and Subsequent Highlights:. --  On September 25, 2025, Anebulo announced the first subjects dosed in a. Phase 1 single ascending dose  study of an intravenous . formulation of its lead drug candidate selonabant. Selonabant is under. development for treatment of acute cannabis-induced toxicity in children.The study will investigate the safety, tolerability, and pharmacokinetics. of selonabant administered intravenously in healthy adult subjects aged. design was cleared by the FDA and is being conducted at a single Phase 1. --  Anebulo has been awarded the second-year tranche  of an. Cunningham continued, \"In addition to the continuing collaborative support from NIDA, our interactions with the Food","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ANEB","BK4007","PCT","ACI","BK4090","BK4113"],"gpt_icon":0},{"id":"2581684830","title":"Anebulo Pharmaceuticals Inc  expected to post a loss of 12 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581684830","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581684830?lang=en_us&edition=fundamental","pubTime":"2025-11-08 08:14","pubTimestamp":1762560844,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Inc  expected to post a loss of12cents a share - Earnings Preview Anebulo Pharmaceuticals Inc ANEB.OQ ANEB.O is expected to  report results on November 11 (estimated) for the p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251108:nL8N3WK00C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","ANEB"],"gpt_icon":0},{"id":"2572599211","title":"Anebulo Pharmaceuticals’ Bold Move: Potential Risks of Going Private with Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2572599211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572599211?lang=en_us&edition=fundamental","pubTime":"2025-10-02 14:01","pubTimestamp":1759384867,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals, Inc. (ANEB) has disclosed a new risk, in the Share Price & Shareholder Rights category. Anebulo Pharmaceuticals, Inc. face...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anebulo-pharmaceuticals-bold-move-potential-risks-of-going-private-with-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anebulo-pharmaceuticals-bold-move-potential-risks-of-going-private-with-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2572586212","title":"Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2572586212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572586212?lang=en_us&edition=fundamental","pubTime":"2025-10-01 14:51","pubTimestamp":1759301463,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals, Inc. ( ($ANEB) ) has released its Q4 earnings. Here is a breakdown of the information Anebulo Pharmaceuticals, Inc. presen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anebulo-pharmaceuticals-advances-cannabis-toxicity-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anebulo-pharmaceuticals-advances-cannabis-toxicity-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2571369995","title":"BRIEF-Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2571369995","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571369995?lang=en_us&edition=fundamental","pubTime":"2025-09-30 06:51","pubTimestamp":1759186311,"startTime":"0","endTime":"0","summary":"BRIEF-Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial ResultsSept 29 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O:ANEBULO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FIS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA8GRTSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ANEB","BK4007"],"gpt_icon":0},{"id":"2571350204","title":"Anebulo Pharmaceuticals Fiscal Q4 Loss Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350204","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350204?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:24","pubTimestamp":1759177491,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals  reported a fiscal Q4 loss late Monday of $0.05 per diluted share, unchanged from a year earlier.An analyst polled by FactSet expected $0.05 loss.The company did not report any revenue for the quarter ended June 30.As of June 30, the company said it had $11.6 million in cash and cash equivalents. It also has access to another $3 million in cash via a loan agreement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2571350571","title":"Anebulo Pharmaceuticals Q4 EPS $(0.05) Beats $(0.08) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350571","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350571?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:12","pubTimestamp":1759176764,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Q4 EPS $(0.05) Beats $(0.08) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/09/47929011/anebulo-pharmaceuticals-q4-eps-0-05-beats-0-08-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Anebulo Pharmaceuticals Q4 EPS $(0.05) Beats $(0.08) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANEB"],"gpt_icon":0},{"id":"2571350864","title":"Anebulo Pharmaceuticals, Inc. Q4 EPS USD -0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350864?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:05","pubTimestamp":1759176300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nPLXCCB29D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","ANEB"],"gpt_icon":0},{"id":"2571350826","title":"Press Release: Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350826","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350826?lang=en_us&edition=fundamental","pubTime":"2025-09-30 04:05","pubTimestamp":1759176300,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects , today announced financial results for the three and twelve months ended June 30, 2025, and recent updates.Fourth Quarter Fiscal Year 2025 and Subsequent Highlights:. --  On September 25, 2025, Anebulo announced the first subjects dosed in a. Phase 1 single ascending dose  study of an intravenous . formulation of its lead drug candidate selonabant. Selonabant is under. development for treatment of acute cannabis-induced toxicity in children.The study will investigate the safety, tolerability, and pharmacokinetics. of selonabant administered intravenously in healthy adult subjects aged. design was cleared by the FDA and is being conducted at a single Phase 1. --  Anebulo has been awarded the second-year tranche  of an. Cunningham continued, \"In addition to the continuing collaborative support from NIDA, our interactions with t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4113","ACI","ANEB","BK4007"],"gpt_icon":0},{"id":"2570018485","title":"Anebulo Pharmaceuticals Initiates Phase 1 Clinical Trial of IV Selonabant for Acute Cannabis-Induced Toxicity in Children","url":"https://stock-news.laohu8.com/highlight/detail?id=2570018485","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570018485?lang=en_us&edition=fundamental","pubTime":"2025-09-25 21:18","pubTimestamp":1758806330,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals Inc. has announced the dosing of the first subjects in its Phase 1 single ascending dose  study of intravenous  selonabant, a drug under development for the treatment of acute cannabis-induced toxicity. The study is being conducted in healthy young adults and is supported by a collaborative grant from the National Institute on Drug Abuse . Selonabant was previously evaluated as an oral treatment in a Phase 2 clinical trial, with the company now prioritizing the IV formulation for potential use in pediatric patients. According to Anebulo, interactions with the U.S. Food and Drug Administration  are ongoing, with a focus on developing selonabant for children exposed to cannabis toxicity. No efficacy or safety results from the current Phase 1 study have been presented yet; further updates are expected as the study progresses.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDLTkxPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANEB","BK4539"],"gpt_icon":0},{"id":"2570928730","title":"Anebulo Pharmaceuticals doses first subjects in selonabant study","url":"https://stock-news.laohu8.com/highlight/detail?id=2570928730","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570928730?lang=en_us&edition=fundamental","pubTime":"2025-09-25 19:45","pubTimestamp":1758800721,"startTime":"0","endTime":"0","summary":"Anebulo Pharmaceuticals (ANEB) announced the first subjects dosed in its Phase 1 single ascending dose study of intravenous selonabant in healthy y...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/anebulo-pharmaceuticals-doses-first-subjects-in-selonabant-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/anebulo-pharmaceuticals-doses-first-subjects-in-selonabant-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANEB","BK4539","BK4007"],"gpt_icon":0},{"id":"2570122091","title":"Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, Under Development for Acute Cannabis-Induced Toxicity","url":"https://stock-news.laohu8.com/highlight/detail?id=2570122091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570122091?lang=en_us&edition=fundamental","pubTime":"2025-09-25 19:30","pubTimestamp":1758799801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nTUA4RXHQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANEB","BK4007","BK4539"],"gpt_icon":0},{"id":"2566707959","title":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2566707959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566707959?lang=en_us&edition=fundamental","pubTime":"2025-09-12 23:04","pubTimestamp":1757689452,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morni","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL3N3UZ10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OEC","WBD","PSKY","COCP","NVDY","NVDU","HOTH","AGAE","00200","LII","NVDS","ANET","SNVD.UK","NVDS.UK","BW","RH","RENT","APUS","CAMT","GCTK","FICO","02018","3NVD.UK","NVIW.SI","NVDD","RNA","NVDX","XTIA","OPI","2NVD.UK","GEV","SJM","NVD","TECH","BGSF","TSYW.SI","ANEB","NXTT","PRE","TT","MSC","OXM","ARRY"],"gpt_icon":1},{"id":"2566972571","title":"BUZZ-Anebulo rises as it weighs going-private deal after getting fresh options","url":"https://stock-news.laohu8.com/highlight/detail?id=2566972571","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566972571?lang=en_us&edition=fundamental","pubTime":"2025-09-12 21:34","pubTimestamp":1757684043,"startTime":"0","endTime":"0","summary":"BUZZ-Anebulo rises as itweighs going-private dealafter getting fresh options** Shares of drug developer Anebulo Pharmaceuticals ANEB.O rise 16.9% to $2.35 in early morning trading ** Anebulo Pharmaceu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL6N3UZ0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","ANEB"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}